BE561270A - - Google Patents
Info
- Publication number
- BE561270A BE561270A BE561270DA BE561270A BE 561270 A BE561270 A BE 561270A BE 561270D A BE561270D A BE 561270DA BE 561270 A BE561270 A BE 561270A
- Authority
- BE
- Belgium
- Prior art keywords
- parts
- solution
- mixture
- hydrochloride
- aminoguanidine
- Prior art date
Links
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 38
- VEXZGXHMUGYJMC-UHFFFAOYSA-N HCl Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 29
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 18
- OKKJLVBELUTLKV-UHFFFAOYSA-N methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 12
- LRHPLDYGYMQRHN-UHFFFAOYSA-N n-butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 claims description 10
- 150000002357 guanidines Chemical class 0.000 claims description 8
- HAMNKKUPIHEESI-UHFFFAOYSA-N aminoguanidine Chemical compound NNC(N)=N HAMNKKUPIHEESI-UHFFFAOYSA-N 0.000 claims description 6
- -1 for example Chemical compound 0.000 claims description 6
- 238000000034 method Methods 0.000 claims description 6
- 150000001728 carbonyl compounds Chemical class 0.000 claims description 4
- 239000012442 inert solvent Substances 0.000 claims description 3
- 238000002360 preparation method Methods 0.000 claims description 3
- 150000003839 salts Chemical class 0.000 claims description 3
- 239000011780 sodium chloride Substances 0.000 claims description 3
- 239000004215 Carbon black (E152) Substances 0.000 claims description 2
- LSNNMFCWUKXFEE-UHFFFAOYSA-M bisulfite Chemical class OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 claims description 2
- 229910052799 carbon Inorganic materials 0.000 claims description 2
- 125000004432 carbon atoms Chemical group C* 0.000 claims description 2
- 125000000623 heterocyclic group Chemical group 0.000 claims description 2
- CPELXLSAUQHCOX-UHFFFAOYSA-N hydrogen bromide Chemical compound Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 claims description 2
- 239000003085 diluting agent Substances 0.000 claims 2
- DNIAPMSPPWPWGF-UHFFFAOYSA-N propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims 1
- 239000000243 solution Substances 0.000 description 52
- RTZKZFJDLAIYFH-UHFFFAOYSA-N diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 36
- 239000000203 mixture Substances 0.000 description 35
- HEMHJVSKTPXQMS-UHFFFAOYSA-M sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 33
- 239000000155 melt Substances 0.000 description 18
- CSCPPACGZOOCGX-UHFFFAOYSA-N acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 16
- 239000007787 solid Substances 0.000 description 14
- 238000010992 reflux Methods 0.000 description 12
- 238000009835 boiling Methods 0.000 description 10
- 239000003208 petroleum Substances 0.000 description 8
- 239000007864 aqueous solution Substances 0.000 description 7
- PMZURENOXWZQFD-UHFFFAOYSA-L na2so4 Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 6
- 229910052938 sodium sulfate Inorganic materials 0.000 description 6
- 235000011152 sodium sulphate Nutrition 0.000 description 6
- 239000002904 solvent Substances 0.000 description 6
- XNLICIUVMPYHGG-UHFFFAOYSA-N 2-Pentanone Chemical compound CCCC(C)=O XNLICIUVMPYHGG-UHFFFAOYSA-N 0.000 description 4
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 4
- CSNNHWWHGAXBCP-UHFFFAOYSA-L mgso4 Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 4
- JHIVVAPYMSGYDF-UHFFFAOYSA-N Cyclohexanone Chemical compound O=C1CCCCC1 JHIVVAPYMSGYDF-UHFFFAOYSA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N acetic acid ethyl ester Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- 238000007792 addition Methods 0.000 description 3
- 230000000172 allergic Effects 0.000 description 3
- 201000008937 atopic dermatitis Diseases 0.000 description 3
- BDERNNFJNOPAEC-UHFFFAOYSA-N propanol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 3
- ABBQHOQBGMUPJH-UHFFFAOYSA-M Sodium salicylate Chemical compound [Na+].OC1=CC=CC=C1C([O-])=O ABBQHOQBGMUPJH-UHFFFAOYSA-M 0.000 description 2
- VHUUQVKOLVNVRT-UHFFFAOYSA-N ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 2
- 235000011114 ammonium hydroxide Nutrition 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- 229920000591 gum Polymers 0.000 description 2
- 230000004968 inflammatory condition Effects 0.000 description 2
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 2
- 235000019341 magnesium sulphate Nutrition 0.000 description 2
- KWOLFJPFCHCOCG-UHFFFAOYSA-N methylphenylketone Chemical compound CC(=O)C1=CC=CC=C1 KWOLFJPFCHCOCG-UHFFFAOYSA-N 0.000 description 2
- 239000008194 pharmaceutical composition Substances 0.000 description 2
- 238000001556 precipitation Methods 0.000 description 2
- 239000011541 reaction mixture Substances 0.000 description 2
- 229960004025 sodium salicylate Drugs 0.000 description 2
- 230000001225 therapeutic Effects 0.000 description 2
- LGVJRKCQQHOWAU-RKDXNWHRSA-N (4aR,8aR)-3,4,4a,5,6,7,8,8a-octahydro-1H-naphthalen-2-one Chemical compound C1CCC[C@@H]2CC(=O)CC[C@H]21 LGVJRKCQQHOWAU-RKDXNWHRSA-N 0.000 description 1
- XMNAHPBYJFGDAC-UHFFFAOYSA-N 1-amino-2-(4-fluorophenyl)guanidine Chemical compound NNC(N)=NC1=CC=C(F)C=C1 XMNAHPBYJFGDAC-UHFFFAOYSA-N 0.000 description 1
- RHXYLNBIHBDYLH-UHFFFAOYSA-N 1-amino-2-phenylguanidine Chemical compound NNC(=N)NC1=CC=CC=C1 RHXYLNBIHBDYLH-UHFFFAOYSA-N 0.000 description 1
- GRGNJBKJCVOFEO-UHFFFAOYSA-N 5-(diethylamino)pentan-2-one Chemical compound CCN(CC)CCCC(C)=O GRGNJBKJCVOFEO-UHFFFAOYSA-N 0.000 description 1
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonium chloride Substances [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 1
- 208000006673 Asthma Diseases 0.000 description 1
- KWHHFIHOZALUSV-UHFFFAOYSA-N Cl.Cl.C(C)C1=CC=C(C=C1)NC(=NN)N Chemical compound Cl.Cl.C(C)C1=CC=C(C=C1)NC(=NN)N KWHHFIHOZALUSV-UHFFFAOYSA-N 0.000 description 1
- CVFBTZQNKXUZTH-UHFFFAOYSA-N Cl.Cl.C1(=CC=C(C=C1)NC(=NN)N)C Chemical compound Cl.Cl.C1(=CC=C(C=C1)NC(=NN)N)C CVFBTZQNKXUZTH-UHFFFAOYSA-N 0.000 description 1
- INGXTCFBAVHAAR-UHFFFAOYSA-N Cl.NNC(=N)NC1=CC=CC=C1 Chemical compound Cl.NNC(=N)NC1=CC=CC=C1 INGXTCFBAVHAAR-UHFFFAOYSA-N 0.000 description 1
- 101700029790 EXE2 Proteins 0.000 description 1
- 208000005679 Eczema Diseases 0.000 description 1
- NTIZESTWPVYFNL-UHFFFAOYSA-N Methyl isobutyl ketone Chemical compound CC(C)CC(C)=O NTIZESTWPVYFNL-UHFFFAOYSA-N 0.000 description 1
- 206010037549 Purpura Diseases 0.000 description 1
- 241001672981 Purpura Species 0.000 description 1
- 208000003385 Rhinitis, Allergic, Seasonal Diseases 0.000 description 1
- 210000000952 Spleen Anatomy 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000002378 acidificating Effects 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000000908 ammonium hydroxide Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 201000004624 dermatitis Diseases 0.000 description 1
- 150000004683 dihydrates Chemical class 0.000 description 1
- 231100001003 eczema Toxicity 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000004907 flux Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxyl anion Chemical compound [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 description 1
- 239000003701 inert diluent Substances 0.000 description 1
- XMBWDFGMSWQBCA-UHFFFAOYSA-M iodide Chemical compound [I-] XMBWDFGMSWQBCA-UHFFFAOYSA-M 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 229940043265 methyl isobutyl ketone Drugs 0.000 description 1
- 150000002894 organic compounds Chemical class 0.000 description 1
- VSVCAMGKPRPGQR-UHFFFAOYSA-N propan-2-one;sulfurous acid Chemical compound CC(C)=O.OS(O)=O VSVCAMGKPRPGQR-UHFFFAOYSA-N 0.000 description 1
- 239000003380 propellant Substances 0.000 description 1
- YGSDEFSMJLZEOE-UHFFFAOYSA-M salicylate Chemical compound OC1=CC=CC=C1C([O-])=O YGSDEFSMJLZEOE-UHFFFAOYSA-M 0.000 description 1
- 229960001860 salicylate Drugs 0.000 description 1
- KEAYESYHFKHZAL-UHFFFAOYSA-N sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- OTNVGWMVOULBFZ-UHFFFAOYSA-N sodium;hydrochloride Chemical compound [Na].Cl OTNVGWMVOULBFZ-UHFFFAOYSA-N 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C281/00—Derivatives of carbonic acid containing functional groups covered by groups C07C269/00 - C07C279/00 in which at least one nitrogen atom of these functional groups is further bound to another nitrogen atom not being part of a nitro or nitroso group
- C07C281/16—Compounds containing any of the groups, e.g. aminoguanidine
- C07C281/18—Compounds containing any of the groups, e.g. aminoguanidine the other nitrogen atom being further doubly-bound to a carbon atom, e.g. guanylhydrazones
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BE561270A true BE561270A (es) |
Family
ID=183275
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BE561270D BE561270A (es) |
Country Status (1)
| Country | Link |
|---|---|
| BE (1) | BE561270A (es) |
-
0
- BE BE561270D patent/BE561270A/fr unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0385850A2 (fr) | Nouveaux dérivés de benzimidazoles et azabenzimidazoles, leurs procédés de préparation, intermédiaires de synthèse, compositions pharmaceutiques les contenant, utiles notamment pour le traitement des maladies cardiovasculaires, et les ulcères duodénaux | |
| FR2676057A1 (fr) | Derives de 1,2-dithiole-3-thione, procede de preparation de ces derives, ainsi que l'utilisation de ces derives comme intermediaires de synthese ou comme medicaments. | |
| BE809234A (fr) | Nouveaux produits a activite anthelminthique | |
| CH407088A (fr) | Procédé de préparation de dérivés des acides 4-halo-3-sulfamoyl-benzoïques | |
| BE561270A (es) | ||
| CA1082716A (fr) | Procede de preparation de nouveaux derives de 5- thiazole methane amine | |
| FR2615188A1 (fr) | Derives d'hydrazine, procede d'obtention et compositions pharmaceutiques les contenant | |
| CH630909A5 (en) | New 3,5-disubstituted-1H-1,2,4-triazoles | |
| BE629779A (es) | ||
| FR2478094A1 (fr) | Derives de cinnamylmoranoline a substitution ammonio, a activite d'inhibition de l'augmentation de niveau de sucre dans le sang | |
| DE2347057A1 (de) | Antimikrobielle mittel | |
| EP0433218B1 (de) | Verfahren zur Herstellung von Aminotriazinderivaten | |
| BE561271A (es) | ||
| DD298928A5 (de) | Neue substituierte heterocyclische fuenfringe, ihre herstellung und verwendung | |
| DE1252204B (de) | Verfahren zur Herstellung von 2,4-Dinitropyrrolderivaten | |
| CH407147A (fr) | Procédé de préparation de composés antitumoraux | |
| CH635314A5 (de) | Verfahren zur herstellung von 2-(phenylalkylhydrazono)-propionsaeurederivaten. | |
| BE706623A (es) | ||
| BE561272A (es) | ||
| BE551306A (es) | ||
| BE653800A (es) | ||
| CH420107A (fr) | Procédé de préparation de nouveaux dérivés d'aralcoylaminoalcoylcyclohexanes substitués | |
| CH471069A (fr) | Procédé de préparation de dérivés de l'acide nitrosolydroxylaminopropionique | |
| BE519639A (es) | ||
| BE849323A (fr) | Derives nouveaux d'alcool benzylique et procedes pour leur preparation |